← BioLineRx Ltd.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Intangible Assets Other Than Goodwill | $181k | $7.0m | $22.0m | $21.9m | $21.7m | $21.7m | $21.9m | $14.9m | $10.4m | $16.4m | |
| Additional Financial Items | |||||||||||
| Issued Capital | $1.5m | $2.8m | $3.1m | $4.7m | $9.9m | $21.1m | $27.1m | $31.4m | $38.1m | $73.4m | |
| Total Assets | $38.9m | $61.0m | $56.2m | $53.6m | $47.3m | $81.4m | $76.4m | $63.9m | $38.9m | $40.9m | |
| LIABILITIES AND EQUITY | |||||||||||
| Total Liabilities | $3.9m | $8.1m | $14.9m | $20.2m | $25.3m | $13.3m | $25.5m | $50.7m | $25.4m | $17.6m | |
| Noncontrolling Interests | — | — | — | — | — | — | — | — | — | $5.1m |